Michael L. Maitland
Impact in
- Immunology top 2%
- Immune Response and Inflammation
- Oncology top 2%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 46
- Colorectal Cancer Treatments and Studies 15
- Cancer Treatment and Pharmacology 13
- HER2/EGFR in Cancer Research 12
-
- PI3K/AKT/mTOR signaling in cancer 10
- Cancer therapeutics and mechanisms 9
- Co-authors
- Mark J. Ratain (35 shared papers)Barry R. Bloom (3 shared papers)Hans D. Brightbill (1 shared paper)John T. Belisle (1 shared paper)Michael V. Norgard (1 shared paper)Stephen T. Smale (1 shared paper)Scott E. Plevy (1 shared paper)Robert L. Modlin (1 shared paper)
- Journals
- Journal of Clinical Oncology (26 papers)Clinical Cancer Research (10 papers)Cancer Research (4 papers)Clinical Pharmacology & Therapeutics (4 papers)JNCI Journal of the National Cancer Institute (3 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Michael L. Maitland
91 papers receiving 4.9k citations
Michael L. Maitland's Hit Papers
Peers
Comparison fields: 5 of 134
- Immunology 1.2k
- Oncology 1.3k
- Cancer Research 690
- Pulmonary and Respiratory Medicine 1.5k
- Microbiology 233
Countries citing papers authored by Michael L. Maitland
This map shows the geographic impact of Michael L. Maitland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Maitland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Maitland more than expected).
Fields of papers citing papers by Michael L. Maitland
This network shows the impact of papers produced by Michael L. Maitland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Maitland. The network helps show where Michael L. Maitland may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael L. Maitland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors Hit paper breakdown → | 1999 | 1363 |
| 2 | Inflammation, Growth Factors, and Pulmonary Vascular Remodeling Hit paper breakdown → | 2009 | 557 |
| 3 | 2010 | 300 | |
| 4 | 2007 | 299 | |
| 5 | 2009 | 212 | |
| 6 | 2012 | 155 | |
| 7 | 2007 | 130 | |
| 8 | 1999 | 128 | |
| 9 | 2009 | 124 | |
| 10 | 2010 | 107 | |
| 11 | 2014 | 105 | |
| 12 | 2012 | 77 | |
| 13 | 2008 | 76 | |
| 14 | 2009 | 74 | |
| 15 | 2012 | 69 | |
| 16 | 2021 | 63 | |
| 17 | 2022 | 57 | |
| 18 | 2017 | 55 | |
| 19 | 2012 | 51 | |
| 20 | 2006 | 49 |
About Michael L. Maitland
Michael L. Maitland is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 94 papers that have together received 5.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (15 papers), Lung Cancer Treatments and Mutations (14 papers), Cancer Treatment and Pharmacology (13 papers), HER2/EGFR in Cancer Research (12 papers), Cancer Genomics and Diagnostics (12 papers), PI3K/AKT/mTOR signaling in cancer (10 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and Cancer therapeutics and mechanisms (9 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.3k citations), Cancer Research (690 citations), Pulmonary and Respiratory Medicine (1.5k citations) and Microbiology (233 citations). Michael L. Maitland has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Mark J. Ratain, Barry R. Bloom, Hans D. Brightbill, John T. Belisle, Michael V. Norgard, Stephen T. Smale, Scott E. Plevy, Robert L. Modlin, Ruey‐Bing Yang and Daniel H. Libraty. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer Research, Clinical Pharmacology & Therapeutics and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.